Paul Tudor Jones Biohaven Pharmaceutical Holding CO Ltd. Transaction History

Tudor Investment Corp Et Al

13 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2022 Nov 14, 2022	BUY	$144.95 - $152.29 $21.3 Million - $22.4 Million	147,269 Added 44.94%	475,004 $71.8 Million
Q2 2022 Aug 15, 2022	BUY	$83.14 - $145.99 $27.2 Million - $47.8 Million	327,735 New	327,735 $47.8 Million
Q4 2021 Feb 14, 2022	SELL	$99.73 - $148.48 $390,044 - $580,705	-3,911 Closed	0 $0
Q3 2021 Nov 15, 2021	BUY	$98.85 - $138.91 $386,602 - $543,277	3,911 New	3,911 $543,000
Q2 2021 Aug 16, 2021	SELL	$65.78 - $105.02 $6.1 Million - $9.73 Million	-92,658 Closed	0 $0
Q1 2021 May 17, 2021	BUY	$64.07 - $91.75 $5.67 Million - $8.12 Million	88,521 Added 2139.74%	92,658 $6.33 Million
Q4 2020 Feb 16, 2021	SELL	$65.07 - $98.24 $17,959 - $27,114	-276 Reduced 6.25%	4,137 $355,000
Q3 2020 Nov 16, 2020	BUY	$59.04 - $77.95 $260,543 - $343,993	4,413 New	4,413 $287,000
Q2 2020 Aug 14, 2020	SELL	$29.01 - $74.23 $551,306 - $1.41 Million	-19,004 Closed	0 $0
Q1 2020 May 15, 2020	SELL	$27.51 - $57.29 $462,443 - $963,044	-16,810 Reduced 46.94%	19,004 $647,000
Q4 2019 Feb 14, 2020	BUY	$40.86 - $57.65 $866,885 - $1.22 Million	21,216 Added 145.33%	35,814 $1.95 Million
Q3 2019 Nov 14, 2019	SELL	$37.38 - $49.47 $504,480 - $667,647	-13,496 Reduced 48.04%	14,598 $609,000
Q2 2019 Aug 14, 2019	BUY	$39.79 - $67.01 $1.12 Million - $1.88 Million	28,094 New	28,094 $1.23 Million

785K

Ticker BHVN
Exchange NYSE
Sector Healthcare
Industry Biotechnology
Shares Outstandng 71,645,000
Market Cap $3.65B
Description
Biohaven Pharmaceutical Holding Company Ltd., a biopharmaceutical company, develops products candidates targeting neurological and neuropsychiatric diseases, and rare disorders in the United States. It offers NURTEC ODT (rimegepant) for the acute treatment of migraine, as well as developing Rimegepant for preventive treatment of migraine; Zavege...

Get notified when there are updates to the investment portfolio of Tudor Investment Corp Et Al, based on Form 13F filings with the SEC.

Stay updated on Tudor Investment Corp Et Al and Paul Tudor Jones with notifications on news.